CIK 0001840706
- Accelerated filer
- Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Other
- Phone
- +41 216941060
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- 4 Grant or award Director acquired 19,724 shares (grant or award)
- 4 Grant or award Director acquired 19,724 shares (grant or award)
- 4 Grant or award Director acquired 19,724 shares (grant or award)
- 4 Grant or award Director acquired 19,724 shares (grant or award)
- 4 Grant or award Director acquired 19,724 shares (grant or award)
- 4 Planned sale Chief Scientific Officer sold 4,000 shares at $5.01 ($20,056)
- 4 Planned sale Chief Medical Officer sold 5,000 shares at $4.95 ($24,752)
- 4 Planned sale Chief Executive Officer sold 8,500 shares at $5.24 ($44,501)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at $4.95 ($99,000)
- 4 Planned sale Chief Medical Officer sold 5,000 shares at $4.95 ($24,774)
- 4 Planned sale President sold 761 shares at $4.60 ($3,501)
- 4 Planned sale Chief Scientific Officer sold 608 shares at $4.60 ($2,798)
- 4 Planned sale Chief Executive Officer sold 4,486 shares at $4.60 ($20,658)
- 4 Planned sale Chief Medical Officer sold 608 shares at $4.61 ($2,800)
- 4 Planned sale Chief Legal Officer sold 684 shares at $4.60 ($3,149)
- 4 Planned sale Chief People Officer sold 380 shares at $4.60 ($1,747)
- 4 Open-market sale Chief Sales Officer sold 33 shares at $4.54 ($150)
- 4 Planned sale Chief Scientific Officer sold 4,000 shares at $4.54 ($18,168)
- 4 Planned sale Director sold 7,508 shares at $4.67 ($35,037)
- 4 Planned sale Chief Medical Officer sold 5,000 shares at $4.67 ($23,345)
Page 4 of 8 · 156 filings